Project Grant HT94252410033
Award Date
5/1/24
Completion Date
4/30/27
Dollars Obligated
$825K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Great Britain, United Kingdom
Similar Awards
The University of Cambridge received a $4,598,677 Project Grant from the Defense Health Agency to conduct research under the Military Medical Research and Development program (CFDA 12.420). The research aims to use multi-modal data integration across breast cancer molecular subtypes to develop predictors of treatment response, early relapse, and survival, as well as explore early signals of later metastatic recurrence. The 4-year grant, which began on September 1, 2023, leverages the...
The University of Cambridge received a $1,996,828.00 four-year Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research to develop predictive models for treatment response, early relapse, and survival in breast cancer across molecular subtypes. The University will leverage multi-modal data integration techniques to explore early signals of later metastatic recurrence. This research aims to...
The University of Cambridge received a $842,452 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on May 1, 2024. The grant supports research to decode the mechanisms of genomic instability in triple-negative breast cancer (TNBC) and how they impact the tissue microenvironment and therapy response at metastatic sites. This 3-year project aims to advance understanding of TNBC biology and identify new therapeutic targets....
The University of Cambridge will receive $439,922 under a three-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from September 2022 through September 2025 to dissect ovarian cancer tumor-immune microenvironments through 3D in situ molecular profiling. The Military Medical Research and Development program aims to transform military and public health through innovative medical research...
This Project Grant from the Defense Health Agency provides $494,811 to the University of Cambridge under the Military Medical Research and Development program (CFDA 12.420) from April 1, 2023 to March 31, 2026. The grant funds research to elucidate and target clonal lineages influencing resistance to therapy in distinct mutational subtypes of high-grade ovarian serous carcinoma. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to...
This Project Grant award from the Defense Health Agency provides $377,681 to the University of Cambridge for research elucidating and targeting clonal lineages influencing resistance to therapy in distinct mutational subtypes of high-grade ovarian serous carcinoma. The award period runs from April 1, 2023 through March 31, 2026. The research funded under this award directly supports the Military Medical Research and Development program's goal of investigating medical solutions for the...
The Department of Defense's Defense Health Agency awarded a $4,818,759 Project Grant to Duke University under the Military Medical Research and Development program (CFDA 12.420) for the project "SINGLE-CELL AND SPATIAL ANALYSIS OF LETHAL BREAST CANCERS". The grant, awarded on April 1, 2024, will fund research to improve understanding and treatment of lethal breast cancers through advanced single-cell and spatial analysis techniques. This work supports the program's goals of...
The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...
The Defense Health Agency awarded a $784,602 Project Grant to Dana-Farber Cancer Institute, Inc. (doing business as Dfci) under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from January 2023 to January 2026 to develop next-generation immunotherapy for breast cancer by turning breast cancer cells against themselves. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
The Defense Health Agency awarded Duke University a $402,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2023 through May 31, 2025. The grant will support Duke University's research efforts to target the ferropotosis protection mechanism of serum to disable cancer metastasis. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions for both...